Your browser doesn't support javascript.
loading
Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
Tofte, N; Lindhardt, M; Adamova, K; Beige, J; Beulens, J W J; Birkenfeld, A L; Currie, G; Delles, C; Dimos, I; Francová, L; Frimodt-Møller, M; Girman, P; Göke, R; Havrdova, T; Kooy, A; Mischak, H; Navis, G; Nijpels, G; Noutsou, M; Ortiz, A; Parvanova, A; Persson, F; Ruggenenti, P L; Rutters, F; Rychlík, I; Spasovski, G; Speeckaert, M; Trillini, M; von der Leyen, H; Rossing, P.
Afiliación
  • Tofte N; Steno Diabetes Centre Copenhagen, Gentofte, Denmark.
  • Lindhardt M; Steno Diabetes Centre Copenhagen, Gentofte, Denmark.
  • Adamova K; University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Skopje, Macedonia.
  • Beige J; Klinikum St. Georg, Nephrology and KfH Renal Unit, Leipzig, Martin-Luther University Halle, Wittenberg, Germany.
  • Beulens JWJ; Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, The Netherlands.
  • Birkenfeld AL; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Currie G; Clinical Study Centre Metabolic Vascular Medicine, GWT TU-Dresden GmbH, Dresden, Germany.
  • Delles C; Paul Langerhans Institute Dresden of the Helmholtz Centre Munich at University Hospital, and Faculty of Medicine, TU Dresden, Dresden, Germany.
  • Dimos I; German Centre for Diabetes Research (DZD e.V.), Neuherberg, Germany.
  • Francová L; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Frimodt-Møller M; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Girman P; Diabetespraxis, Leipzig, Germany.
  • Göke R; 1st Department, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
  • Havrdova T; Steno Diabetes Centre Copenhagen, Gentofte, Denmark.
  • Kooy A; Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Mischak H; Diabetologische Schwerpunktpraxis, Diabetologen Hessen, Marburg, Germany.
  • Navis G; Diabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Nijpels G; Bethesda Diabetes Research Centre, Hoogeveen and University Medical Centre Groningen, Netherlands.
  • Noutsou M; Mosaiques Diagnostics, Hannover, Germany.
  • Ortiz A; Division of Nephrology, Department of Internal Medicine, University Medical Centre Groningen, Groningen, Netherlands.
  • Parvanova A; Department General Practice and Elderly Care, Amsterdam Public Health VU University Medical Centre, Amsterdam, The Netherlands.
  • Persson F; Diabetes Centre and 2nd Department of Internal Medicine, National and Kapodistrian University of Athens, Hippokratio General Hospital, Athens, Greece.
  • Ruggenenti PL; Instituto de Investigacion Sanitaria de la Fundacion Jiménez Díaz UAM, Madrid, Spain.
  • Rutters F; Istituto di Richerche Farmacologiche Mario Negri, Bergamo, Italy.
  • Rychlík I; Steno Diabetes Centre Copenhagen, Gentofte, Denmark.
  • Spasovski G; Istituto di Richerche Farmacologiche Mario Negri, Bergamo, Italy.
  • Speeckaert M; Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, The Netherlands.
  • Trillini M; 1st Department, Charles University, Third Faculty of Medicine, Prague, Czech Republic.
  • von der Leyen H; Faculty Hospital Královské Vinohrady, Prague, Czech Republic.
  • Rossing P; Department of Nephrology, Cyril and Methodius University in Skopje, Skopje, Macedonia.
Diabet Med ; 35(10): 1375-1382, 2018 10.
Article en En | MEDLINE | ID: mdl-29781558
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteoma / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Antagonistas de Receptores de Mineralocorticoides / Hipoglucemiantes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteoma / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Antagonistas de Receptores de Mineralocorticoides / Hipoglucemiantes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabet Med Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Dinamarca